Camino Estivill
- Hematology top 5%
- Acute Myeloid Leukemia Research 10
-
- Chronic Lymphocytic Leukemia Research 5
-
- Lymphoma Diagnosis and Treatment 6
-
- Cancer Genomics and Diagnostics 3
-
- Acute Lymphoblastic Leukemia research 3
-
- Viral-associated cancers and disorders 4
-
- Immune Cell Function and Interaction 3
- Immunodeficiency and Autoimmune Disorders 2
Camino Estivill
21 papers receiving 322 citations
Peers
Comparison fields: 5 of 37
- Hematology 195
- Genetics 78
- Pathology and Forensic Medicine 59
- Cancer Research 43
- Public Health, Environmental and Occupational Health 79
Countries citing papers authored by Camino Estivill
This map shows the geographic impact of Camino Estivill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camino Estivill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camino Estivill more than expected).
Fields of papers citing papers by Camino Estivill
This network shows the impact of papers produced by Camino Estivill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camino Estivill. The network helps show where Camino Estivill may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Camino Estivill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 30 | |
| 2 | 2016 | 3 | |
| 3 | 2013 | 57 | |
| 4 | 2012 | 32 | |
| 5 | 2009 | 17 | |
| 6 | 2008 | 20 | |
| 7 | 2006 | 2 | |
| 8 | 2005 | 10 | |
| 9 | 2004 | 35 | |
| 10 | 2003 | 14 | |
| 11 | Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia. | 2003 | 28 |
| 12 | 2002 | 2 | |
| 13 | Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement. | 2002 | 9 |
| 14 | 2001 | 10 | |
| 15 | 2001 | 1 | |
| 16 | 1999 | 19 | |
| 17 | 1998 | 13 | |
| 18 | 1998 | 1 | |
| 19 | Aggressive natural killer cell leukemia: report of a case in a Caucasian boy. | 1998 | 9 |
| 20 | Rapid and simple immunophenotypic characterization of lymphocytes using a new test. | 1998 | 10 |
About Camino Estivill
Camino Estivill is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 21 papers that have together received 328 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Viral-associated cancers and disorders (4 papers), Immune Cell Function and Interaction (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer Genomics and Diagnostics (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Hematology (195 citations), Genetics (78 citations) and Pathology and Forensic Medicine (59 citations). Camino Estivill has collaborated with scholars based in Spain and Italy. Frequent co-authors include Josep Nomdedéu, Jorge Sierra, Salut Brunet, Adriana Lasa, Anna Aventı́n, Maria J. Carnicer, Elena Bussaglia, Montserrat Hoyos, R Bordés and Mar Bellido. Their work appears in journals such as Leukemia, American Journal of Clinical Pathology and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.